Sufferers of type 2 diabetes may one day be able to control their condition and reduce the number of...
Sufferers of type 2 diabetes may one day be able to control their condition and reduce the number of injections they have to take each week from 14 to one, if Canadian research comes to fruition. Researchers at the University of Toronto discovered a re-formulated version of the drug Exenatide was better at controlling blood sugar levels than the current one, which needs to be injected twice a day. The preliminary study reported its findings as: "Exenatide once weekly resulted in significantly greater improvements of glycaemic control than Exenatide given twice a day, with no increased r...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes